NTRA Stock Analysis: Buy, Sell, or Hold?

NTRA - Natera, Inc. Common Stock

SERVICES-MEDICAL LABORATORIES
$270.36
2.60 (0.97%) ▲
5d: +4.78%
30d: -3.21%
90d: +30.43%
BUY
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 06, 2026 1d
Smart Money Accumulation

None View Scanner →

Strength: 6.6/10

Get Alerted When NTRA Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
💡 BUY OPPORTUNITY: NTRA shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
See Forward Earnings Fair Value & Price Prediction →

In-depth Analysis How we analyze

Valuation Analysis: NTRA is currently trading at $270.36, which is considered fair relative to its 30-day fair value range of $254.01 to $278.62.

Technical Outlook: Technically, NTRA is in a strong uptrend. The price is approaching resistance at $275.12. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.

Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position FAIR
Historical Trading Range $254.01 - $278.62
Company Quality Score 59/100 (HOLD)
Volume Confirmation HIGH
Confidence Score 69.5%

All Signals

  • NEUTRAL: Price in fair range
  • NEUTRAL: Mixed technical signals (40/100)
  • BULLISH: High volume confirmation
  • NEUTRAL: Near Wall St target ($282.86)

Trading Range Analysis

30-Day Trading Range $254.01 - $278.62
Current vs Trading Range FAIR

Support & Resistance Levels

Support Level $248.03
Resistance Level $275.12
Current Trend Strong Uptrend
Technical data as of Aug 3, 2026

Fundamental Context

Forward P/E (Next Year Est.) -1308.06
Wall Street Target $282.86 (+5.6%)
Revenue Growth (YoY) 38.8%
Profit Margin -9.0%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: August 04, 2026 1:41 AM ET
Data refreshes hourly during market hours. Next update: 2:41 AM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
8
Sells
Net
INSIDERS SELLING
Recent Transactions
Solomon Moshkevich SELL 3000 shares 2026-04-01
Rowan E Chapman SELL 122 shares 2026-03-13
John Fesko SELL 707 shares 2026-03-10

Unlock Insider Activity

See real-time buying/selling by company executives for NTRA.

Create Free Account

Already have an account? Log In

Top Rated Diagnostics & Research Stocks

Top-rated stocks in Diagnostics & Research by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
TMO
Thermo Fisher Scientific…
STRONG BUY
31 analysts
$630 53 HOLD
EXAS
EXACT Sciences Corporati…
STRONG BUY
26 analysts
$106 65 BUY
GH
Guardant Health Inc
STRONG BUY
23 analysts
$188 61 BUY
DHR
Danaher Corporation
STRONG BUY
25 analysts
$228 52 HOLD
IQV
IQVIA Holdings Inc
BUY
23 analysts
$273 64 BUY

Advanced NTRA Option Strategies

Professional options setups generated by AI based on today's NTRA price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for NTRA

NTRA Technical Chart NTRA Price Prediction NTRA Earnings Date NTRA Investment Advisor NTRA Fair Price Analyzer NTRA Options Advisor NTRA Options Chain NTRA Options Analysis NTRA Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals